Abstract
Thermo Fisher Scientific plans to buy Finesse Solutions, a maker of process sensors, controllers, and software for biopharmaceutical production with annual sales of $50 million. Terms of the transaction were not disclosed. A key motivator behind the acquisition is Finesse’s development of a universal control system that “will combine seamlessly with our existing single-use technologies,” Thermo Fisher CEO Marc N. Casper says.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
